Log in
Enquire now
‌

US Patent 7632938 siRNA targeting superoxide dismutase 1 (SOD1)

Patent 7632938 was granted and assigned to Dharmacon, Inc. on December, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Dharmacon, Inc.
Dharmacon, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
76329380
Patent Inventor Names
William Marshall0
Anastasia Khvorova0
Angela Reynolds0
Devin Leake0
Stephen Scaringe0
Steven Read0
Date of Patent
December 15, 2009
0
Patent Application Number
119785180
Date Filed
October 29, 2007
0
Patent Citations Received
‌
US Patent 12123002 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
0
‌
US Patent 12116589 Treatment of amyotrophic lateral sclerosis (ALS)
0
Patent Primary Examiner
‌
Sean R. McGarry
0
Patent abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for SOD1.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7632938 siRNA targeting superoxide dismutase 1 (SOD1)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.